Symptom burden to characterise, predict, and prevent asthma attacks: a patient-level meta-analysis of randomised trials and translational prospective studies

Study limitation reported by the research below: “The DREAM dataset used IV mepolizumab (not the approved SC formulation), which may limit direct translation to current clinical practice.”